Skip to content

Effect of intravenous lidocaine infusion on analgesic efficacy and brain protection in patients undergoing craniotomy

Effect of intravenous lidocaine infusion on analgesic efficacy and brain protection in patients undergoing craniotomy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086157
Enrollment
Unknown
Registered
2024-06-26
Start date
2023-10-07
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Lidocaine group:1. Before anesthesia induction: 1.5mg/kg lidocaine intravenous infusion for 10 minutes, the maximum dose does not exceed 100mg 2. After intubation to the end of surgery: Intravenous co
Sufentanil group:1. Before anesthesia induction: intravenous infusion of normal saline of the same volume at a rate of 1.5mg/kg/h for 10 minutes 2. After intubation to the end of surgery: intravenous

Sponsors

Gansu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled to undergo elective cranial mass resection during general anesthesia; 2. Age 18-65 years old; 3. ASA Grading I- III; 4. Preoperative Glasgow coma score of 15 points; 5. The score of the preoperative Mini-Mental State Examination Scale > 24 points to rule out the influence of preoperative neuropsychological dysfunction.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the drugs used in the study; 2. History of previous craniotomy, systemic malignancy, diabetes, psychiatric disorder, alcoholism, and drug abuse; 3. Radiotherapy/chemotherapy before or after surgery; 4. Abnormal liver and kidney function, severe cardiopulmonary failure; 5. Body mass index (BMI) 28 kg/cm2; 6. Inability to use the PCIA device or understand the pain VAS score

Design outcomes

Primary

MeasureTime frame
Pain VAS score;

Secondary

MeasureTime frame
S100 beta protein;Neuron specific enolase;Perioperative total opioid consumption ;Mean arterial pressure;Heart rate;Postoperative quality of recovery score;The number of PCIA compressions and the number of effective compressions at 48 hours after surgery;Interleukin-6;Tumor necrosis factor alpha;C-reaction protein;Lidocaine blood concentration;

Countries

China

Contacts

Public ContactYan Wenjun

Gansu Provincial People's Hospital

13893370700@163.com+86 138 9337 0700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026